Delivery Order SPE2DR25D2206-SPE2DR26F9LL2
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,066.16 to AmerisourceBergen Drug Corp for Nemluvio 30 mg pens on December 2, 2025, with an ultimate completion date of December 23, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $4,066.16 to AmerisourceBergen Drug Corp for the supply of Nemluvio 30 mg pens, with an ultimate completion date of February 2, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (doing business as...
- The Defense Logistics Agency awarded a $2,033.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 13, 2026, for supply of Nemluvio 30 mg pens, with completion targeted for February 4, 2026. This is a non-set-aside, competitively awarded contract with performance taking place at the company's headquarters in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,066.16 to AmerisourceBergen Drug Corp for the supply of Nemluvio 30 mg pens. The contract, executed on November 28, 2025, with a completion date of December 19, 2025, carries firm fixed-price terms and is classified as a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform fulfillment at its corporate office location....
- The Defense Logistics Agency awarded a delivery order valued at $2,033.08 to AmerisourceBergen Drug Corp for Nemluvio 30 mg pens on January 5, 2026, with completion scheduled for January 27, 2026. This firm fixed-price delivery order represents a non-competitive award under the contractor's existing indefinite delivery contract vehicle with DLA. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal...
- The Defense Logistics Agency awarded a $4,066.16 delivery order to AmerisourceBergen Drug Corp for Nemluvio 30 mg pens, with an ultimate completion date of January 12, 2026. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a delivery order valued at $1,929.20 to AmerisourceBergen Drug Corp for the supply of Nemluvio 30 mg pens, with an ultimate completion date of August 11, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in Conshohocken, PA 19428. This delivery order...
- The Defense Logistics Agency awarded a $4,066.16 delivery order to AmerisourceBergen Drug Corp for Nemluvio 30 mg pens on January 5, 2026, with a completion date of January 27, 2026. This firm fixed-price, non-set-aside contract was issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $4,066.16 to AmerisourceBergen Drug Corp for the supply of Nemluvio 30 mg pens. This firm fixed-price delivery order, issued on December 1, 2025, with completion expected by December 22, 2025, represents a non-competitive, non-set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $4,066.16 to AmerisourceBergen Drug Corp for Nemluvio 30 mg pens on December 15, 2025, with an ultimate completion date of January 7, 2026. This is a firm fixed price delivery order with no set-aside designation, performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a competitively awarded transaction under AmerisourceBergen's existing contract vehicle with DLA. This delivery...
- SPE2DR25D2206Indefinite Delivery Contract
- SPE2DR25D2206-SPE2DR26F9LL2Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,066.16 to AmerisourceBergen Drug Corp for the supply of Nemluvio 30 mg pens, with an ultimate completion date of February 6, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The contract supports critical customer groups including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 1/14/26 |